logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
E

Emiliano Calvo

centro integral oncologico clara campal

58H指数
670论文数
1.6W被引数
收录论文 175
发表时间
logo
Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trialWerner解旋酶抑制剂用于高级别微卫星不稳定性实体瘤：一项1期临床试验
errNature Medicine
IF50
err2026-09-29
err0
errOAAI
errTimothy A. Yap; Elisa Fontana; Natalie Cook; Marwan Fakih; Oliver Bechter; Erica S. Tsang; Emiliano Calvo; Kristoffer S. Rohrberg; Javier Ros; Ignacio Matos; John H. Strickler; Malaka Ameratunga; Meredith Pelster; Adam Sharp; Jaspreet Grewal; Susanna Ulahannan; Rajesh Belani; Matthew P. Patricelli; Sophia M. Blake; David Dejardin; Stephen Fowler; Christina Godfried Sie; Astrid Heller; Nina Henkel; Michael Hettich; Angelika Lahr; David Lamparter; Charlotte Lane; Ting Liu; Hélène Meistermann; Christophe Meille; Neil Parrott; Sotirios K. Sotiriou; Denise Reeves; Barbara Romagnoli; Piergiorgio Pettazzoni; Daniel Waterkamp; Matthias Wittwer; Yali Fu; Sophie Postel-Vinay
err分享
err收藏
16 ABBV-CLS-484: A Novel Oral PTPN2/1 Inhibitor for Cancer Immunotherapy16 ABBV-CLS-484：一种新型口服PTPN2/1抑制剂用于癌症免疫疗法
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errHans Hammers; Emiliano Calvo; Benedito A Carneiro; Michael R Harrison; Eric Jonasch; David Braun; Do-Youn Oh; Kartik Seghal; Ulka Vaishampayan; Noboru Yamamoto; Leisha A Emens; Jie Tang; Anh Nguyen; Nidhi Prem; Damian Trujillo; Cathleen Hartman; Marcia Paddock; Jonathan Powell; David McDermott
err分享
err收藏
An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial在GNAQ/GNA11突变型黑色素瘤中具有Gq/11抑制剂载荷的抗PMEL抗体−药物偶联物：一项1期临床试验
errNature Medicine
IF50
err2026-07-13
err0
errOAAI
errMatteo S. Carlino; Ellen Kapiteijn; Sophie Piperno-Neumann; Ryan J. Sullivan; Richard Carvajal; Reinhard Dummer; Tanja Gromke; Jessica C. Hassel; Damien Kee; Egle Ramelyte; Alexander N. Shoushtari; Alexander Z. Wei; Alexander Enk; Eleanor E. Handel; Kamaneh Montazeri; Jorge Ramon-Patino; Heike Richly; Manuel Rodrigues; Shahneen Sandhu; James Smithy; Frank M. Speetjens; Pedro Milanez-Almeida; Anwesha Chaudhury; Keith Hoffmaster; Mary Ising; Javier A. Otero; Thiruvamoor RamKumar; Aimee Reynolds; Sherif Sharaby; Lillian Werner; Padmaja Yerramilli-Rao; Emiliano Calvo
err分享
err收藏
Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer癌症患者中的人体吸收、代谢和排泄（hAME）质量平衡研究
errClinical and Translational Science
IF2.8
err2026-05-29
err0
errOAAI
errBegoña de las Heras; Claudine Oelke; Pamela Atwell; Hector Herrero; Paulo Nunes; Kamal S. Saini; Laura Vidal Boixader; Catherine Laing; James Bush; Emiliano Calvo
err分享
err收藏
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity六聚体抗体HexaBody-DR5/DR5在恶性实体瘤中的安全性与有效性：I/IIa期试验结果及对观察到肝毒性的转化医学见解
errClinical and Translational Science
IF2.8
err2026-05-22
err0
errOAAI
errMarije B. Overdijk; Kristin Strumane; Ruth Plummer; Patricia LoRusso; Jordi Rodon Ahnert; Udai Banerji; Elena Garralda; Emiliano Calvo; Han Si; Naomi Hoevenaars; Jens Thing Mortensen; Sieto Bosgra; Anders Malmberg; Merete Ellekilde-Pedersen; Teresa Ramirez-Andersen; Panagiota Diamantopoulou Reiter; Elena Favaro; Ulf Forssmann; Esther C. W. Breij; Maria Jure-Kunkel
err分享
err收藏
Datopotamab Deruxtecan Plus Pembrolizumab With or Without Platinum-Based Chemotherapy for Advanced or Metastatic NSCLC: The Phase Ib TROPION-Lung02 TrialDatopotamab Deruxtecan 联合帕博利珠单抗，联合或不联合铂类化疗治疗晚期或转移性非小细胞肺癌：TROPION-Lung02 Ib期试验
errJournal of Thoracic Oncology
IF20.8
err2026-03-21
err0
PREAI
errBenjamin Levy; Luis Paz-Ares; Chien-Chung Lin; Scott Herbert; Tsung-Ying Yang; Anthony Tolcher; Yanyan Lou; Yoshitaka Zenke; Diego Cortinovis; Enriqueta Felip; Manuel Domine; Konstantinos Leventakos; Emiliano Calvo; Atsushi Horiike; Edward Pan; Priyanka Basak; Daisy Lin; Wen Gu; Rachel Chiaverelli; Michael J. Chisamore
err分享
err收藏
Understanding the Chemical Characteristics of Payloads and the Expression of Tumor-Associated Antigens of ADCs in Clinical Development
errACS OMEGA
IF4.3
err2025-11-01
err0
PREAI
errNieto-Jimenez, Cristina; Paniagua-Herranz, Lucia; Bosi, Carlo; Poyatos-Racionero, Elisa; Pedregal, Manuel; Moreno, Victor; Calvo, Emiliano; Dominguez-Jurado, Elena; Hernandez, Tatiana; Perez-Segura, Pedro; Gyorffy, Balazs; Alonso-Moreno, Carlos; Bianchini, Giampaolo; Ocana, Alberto
err分享
err收藏
Mapping MAGE-A4 expression in solid cancers for targeted therapies
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-03-13
err0
errOAAI
errHabigt, Christin; Rottey, Sylvie; Spanggaard, Iben; Lopez, Juanita S.; Garralda, Elena; Calvo, Emiliano; Bechter, Oliver; Desai, Jayesh; Galot, Rachel; Gandhi, Leena; Heil, Florian; Rieder, Natascha; Dimitrov, Ivan; Quetglas, Iris Martinez; Heichinger, Christian; Keshelava, Nino; Roller, Andreas
err分享
err收藏
Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER StudyLurbinectedin联合Pembrolizumab治疗复发性小细胞肺癌: I/II期LUPER研究
errJournal of Thoracic Oncology
IF20.8
err2025-02-10
err0
PREAI
errAntonio Calles; Alejandro Navarro; Bernard Gaston Doger de Speville Uribe; Enric Álvarez Colomé; María de Miguel; Rosa Álvarez; Marta Arregui; Víctor Moreno; Pedro Rocha; Emiliano Calvo; Jorge Ramon-Patino; Elena Corral de la Fuente; Daniel Alcalá-López; Olga Boix; Melissa Fernández-Pinto; Jose Rodríguez-Morató; Ramón Palmero; Ernest Nadal; Maria Jove; Enriqueta Felip
err分享
err收藏
A PRELIMINARY SIGNS OF CLINICAL ACTIVITY OF TUVUSERTIB (M1774), A HIGHLY POTENT ORAL ATR INHIBITOR, IN REFRACTORY IDH MUTATED GLIOMA PATIENTS WITH P53 AND ATRX MUTATIONS; A CASE SERIES FROM A FIH STUDY
errNEURO-ONCOLOGY
IF13.4
err2024-10-17
err0
PREAI
errVieito, M.; Moreno, I; Gomez-Puerto, D.; Ruiz, I. Victoria; Indacochea, A.; Garralda, E.; Gonzalez, S.; Calvo, E.; Juanita, L.; Szucs, Z.; Reischmann, N.; Pineda, E.
err分享
err收藏
Comparison of single agent versus combination activity of enfortumab vedotin (EV) and sacituzumab govitecan (SG) in a panel of bladder cancer XPDX models
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-10-01
err0
PREAI
errSimonson, A.; Flores, J.; Mercer, G.; Lopez, M.; Garcia, R.; Lund, J.; Banos, N.; Papadopoulos, K.; Calvo, E.; Pedregal, M.; Hernandez, T.; Rasco, D.; Patnaik, A.; Garcia-Foncillas, J.; Wick, M.
err分享
err收藏
Phase I/Ib open-label study of an HER2-targeted T cell engager (TCE)-SAR443216 in patients (pts) with advanced solid tumors: Intravenous (IV) dose-escalation resultsI期/ Ib期开放标签研究：HER2靶向T细胞接合剂（TCE）SAR443216在晚期实体瘤患者（pts）中的静脉（IV）剂量递增结果
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMoreno Garcia, V.; Oh, D-Y.; Ryu, M. H.; Calvo, E.; Garralda, E.; Chung, W-P.; Bai, L-Y.; Rojas Laimito, K. I.; Yildirim, O.; Masciari, S.; Mi, G.; Wang, L.; Kanlikilicer, P.; Buday, B.; Rharbaoui, F.; Abbadessa, G.; Dumbrava, E. E.
err分享
err收藏
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trialsCEA阳性实体瘤患者CEA-CD3双特异性抗体cibisatamab加或不加阿特珠单抗: 两项多机构1期试验的结果
errNATURE COMMUNICATIONS
IF15.7
err2024-05-15
err4
errOAAI
errSegal, Neil H.; Melero, Ignacio; Moreno, Victor; Steeghs, Neeltje; Marabelle, Aurelien; Rohrberg, Kristoffer; Rodriguez-Ruiz, Maria E.; Eder, Joseph P.; Eng, Cathy; Manji, Gulam A.; Waterkamp, Daniel; Leutgeb, Barbara; Bouseida, Said; Flinn, Nick; Das Thakur, Meghna; Elze, Markus C.; Koeppen, Hartmut; Jamois, Candice; Martin-Facklam, Meret; Lieu, Christopher H.; Calvo, Emiliano; Paz-Ares, Luis; Tabernero, Josep; Argiles, Guillem
err分享
err收藏
Activity of alpelisib in a panel of breast XPDX models harboring hotspot and uncommon PIK3CA mutations
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errCastaneda, Mercedes; Simonson, Alyssa; Flores, Johnnie; DeBoer, Maci; Lund, Jim; Rouzbahan, Tahmi; Papadopoulos, Kyriakos P.; Lang, Amy; Rodriguez, Gladys; Elmi, Maryam; Rosenthal, Arthur; Rasco, Drew; Moreno, Victor; Patnaik, Amita; Hernandez, Tatiana; Calvo, Emiliano; Smith, Lon; Sharma, Manish; Beeram, Muralidhar; Wick, Michael
err分享
err收藏
Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug-Drug Interaction Study
errMARINE DRUGS
IF5.4
err2024-04-16
err0
errOAAI
errMoreno, Irene; Hernandez, Tatiana; Calvo, Emiliano; Fudio, Salvador; Kahatt, Carmen; Martinez, Sara; Iglesias, Jorge Luis; Calafati, Roman Octavio; Perez-Ramos, Laura; Montilla, Lola; Zeaiter, Ali; Lubomirov, Rubin
err分享
err收藏
Establishment and characterization of a panel of naive and pretreated small cell lung cancer (SCLC) XPDX models
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errMorales, Gabriela Huelgas; Forofontov, Peter; Flores, Johnnie; Simonson, Alyssa; Diaz, Armando, III; Lund, Jim; Banos, Natalia; Papadopoulos, Kyriakos; Rasco, Drew; Patnaik, Amita; Abedi, Ali; Puente, Napoleon; Calvo, Emiliano; Moreno, Victor; Drengler, Ronald; Smith, Lon; Wick, Michael
err分享
err收藏
Enfortumab vedotin (EV): Efficacy comparison with trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) and its potential for combination benefit in bladder cancer XPDX models
errCANCER RESEARCH
IF16.6
err2024-03-22
err1
PREAI
errFlores, Johnnie; Sessions, Heaven; Simonson, Alyssa; Banos, Natalia; Rouzbahani, Tahmineh; Diaz, Armando, III; Lund, Jim; Calvo, Emiliano; Moreno, Victor; Papadopoulos, Kyriakos; Rasco, Drew; Patnaik, Amita; Ulmer, Scott; Rodriguez, Luis; Wick, Michael
err分享
err收藏
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses基于病毒载体的个性化疫苗接种的I期试验引发了强大的新抗原特异性抗肿瘤T细胞反应
errCLINICAL CANCER RESEARCH
IF10.2
err2024-03-20
err7
errOAAI
errD'Alise, Anna Morena; Leoni, Guido; Cotugno, Gabriella; Siani, Loredana; Vitale, Rosa; Ruzza, Valentino; Garzia, Irene; Antonucci, Laura; Micarelli, Elisa; Venafra, Veronica; Gogov, Sven; Capone, Alessia; Runswick, Sarah; Martin-Liberal, Juan; Calvo, Emiliano; Moreno, Victor; Symeonides, Stefan N.; Scarselli, Elisa; Bechter, Oliver
err分享
err收藏
MYC targeting by OMO-103 in solid tumors: a phase 1 trial
errNATURE MEDICINE
IF50
err2024-02-06
err30
errOAAI
errGarralda, Elena; Beaulieu, Marie-Eve; Moreno, Victor; Casacuberta-Serra, Silvia; Martinez-Martin, Sandra; Foradada, Laia; Alonso, Guzman; Masso-Valles, Daniel; Lopez-Estevez, Sergio; Jauset, Toni; de la Fuente, Elena Corral; Doger, Bernard; Hernandez, Tatiana; Perez-Lopez, Raquel; Arques, Oriol; Cano, Virginia Castillo; Morales, Josefa; Whitfield, Jonathan R.; Niewel, Manuela; Soucek, Laura; Calvo, Emiliano
err分享
err收藏
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study中度CYP3A4诱导剂 (波生坦) 对晚期实体瘤患者Lurbinectedin药代动力学和安全性的影响: 一项开放标签，双向，交叉，Ib期药物-药物相互作用研究
errPHARMACEUTICALS
IF4.8
err2024-01-30
err1
errOAAI
errMoreno, Irene; Hernandez, Tatiana; Calvo, Emiliano; Fudio, Salvador; Kahatt, Carmen; Fernandez, Cristian; Iglesias, Jorge Luis; Corral, Gema; Perez-Ramos, Laura; Montilla, Lola; Zeaiter, Ali; Lubomirov, Rubin
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Johann S. de Bono
H 指数: 160 · 论文数: 2.5K
F
F. Stephen Hodi
H 指数: 156 · 论文数: 1.5K
F
Fabrice André
H 指数: 148 · 论文数: 1.8K
R
Robert J. Motzer
H 指数: 148 · 论文数: 1.6K
F
Funda Meric‐Bernstam
H 指数: 146 · 论文数: 2.6K
查看更多